Published
Interim results of Oxford University's Phase I/II trial of a COVID-19 vaccine were published today in the scientific journal, The Lancet.
They indicate no safety concerns, as well as T-cell and antibody responses against the SARS-CoV-2 virus, and neutralising antibody response. The trials will continue, in order to find out whether these responses are the type and strength needed to fight the virus.
Find out more about the vaccine: https://www.ox.ac.uk/covid-vaccine
They indicate no safety concerns, as well as T-cell and antibody responses against the SARS-CoV-2 virus, and neutralising antibody response. The trials will continue, in order to find out whether these responses are the type and strength needed to fight the virus.
Find out more about the vaccine: https://www.ox.ac.uk/covid-vaccine
- Category
- Academic
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
03:54
Why You Should Still Get The Vaccine If You've Already Had Covid | Dr. Ian Smith
-
10:36
Covid-19: Will vaccine be for all? News Review
-
00:55
The Black Death today: Oxford launches clinical trial of a plague vaccine
-
00:49
Oxford launches trials for new oral vaccine against paratyphoid
-
02:36
Human challenge trial to study immune response to COVID-19
-
14:01
MMR Vaccine Was Approved After Small Studies With Disturbing Results
-
00:55
Oxford's malaria vaccine - The story so far
-
00:54
Human trial of new COVID-19 vaccine begins
-
34:09
The 5:30 A.M. Warrior Call: COVID-19 Vaccine to Begin Human Trial (4/07/2020)
-
02:12
COVID Vaccine: What are its greatest challenges?
-
06:18
COVID-19 coronavirus vaccine: everything you need to know
-
04:01
What's a human challenge trial of COVID-19 like?
-
11:05
Covid-19: Drug trial gives hope: BBC News Review
-
01:00
The world's biggest randomised clinical trial of COVID-19 treatments is a year old
-
01:51
Coronavirus: How long will it take to develop a Covid-19 vaccine?
-
02:01
African Research, Oxford Vaccine
-
03:20
Oxford's COVID-19 vaccine is highly effective: Phase III trial interim results
-
01:36
Cancer Vaccine Trial Starting on Patients
-
02:30
Oxford's scientists explain the Phase I/II results for the COVID-19 vaccine
-
25:50
COVID Conversations: Oxford's COVID-19 Government Response Tracker
-
00:48
Oxford University's 'vaccine for the world' is effective
-
00:50
WHO recommends Oxford vaccine against malaria
